Kineret

KINERET (Anakinra)

KINERET

Anakinra

100 mg/0.67 mL solution for Subcutaneous Injection

Swedish Orphan Biovitrum AB

Medical Use

Kineret (Anakinra 100 mg / 0.67 mL solution) is an interleukin-1 receptor antagonist used for:

  • -Rheumatoid Arthritis (RA): It helps reduce signs and symptoms and slows the progression of structural damage in adults (18 years and older) with moderately to severely active RA who have not responded well to one or more disease-modifying antirheumatic drugs (DMARDs).
  • -Cryopyrin-Associated Periodic Syndromes (CAPS): It is used to treat Neonatal-Onset Multisystem Inflammatory Disease (NOMID).

Kineret (Anakinra) is an FDA-approved medication.